These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 17646417)

  • 1. Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus.
    Pereira PM; Filipe SR; Tomasz A; Pinho MG
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3627-33. PubMed ID: 17646417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds.
    Pfeltz RF; Singh VK; Schmidt JL; Batten MA; Baranyk CS; Nadakavukaren MJ; Jayaswal RK; Wilkinson BJ
    Antimicrob Agents Chemother; 2000 Feb; 44(2):294-303. PubMed ID: 10639353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing Trend of Heterogeneous Vancomycin Intermediate Staphylococcus aureus in a Tertiary Care Center of Northern India.
    Singh A; Prasad KN; Misra R; Rahman M; Singh SK; Rai RP; Tripathi A; Srivastava JK
    Microb Drug Resist; 2015 Oct; 21(5):545-50. PubMed ID: 26430942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.
    Cui L; Iwamoto A; Lian JQ; Neoh HM; Maruyama T; Horikawa Y; Hiramatsu K
    Antimicrob Agents Chemother; 2006 Feb; 50(2):428-38. PubMed ID: 16436693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical isolate of vancomycin-heterointermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative.
    Bobin-Dubreux S; Reverdy ME; Nervi C; Rougier M; Bolmström A; Vandenesch F; Etienne J
    Antimicrob Agents Chemother; 2001 Jan; 45(1):349-52. PubMed ID: 11120996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Rose WE; Knier RM; Hutson PR
    J Antimicrob Chemother; 2010 Oct; 65(10):2149-54. PubMed ID: 20693174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
    Pieper R; Gatlin-Bunai CL; Mongodin EF; Parmar PP; Huang ST; Clark DJ; Fleischmann RD; Gill SR; Peterson SN
    Proteomics; 2006 Aug; 6(15):4246-58. PubMed ID: 16826566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus.
    Sieradzki K; Tomasz A
    J Bacteriol; 2003 Dec; 185(24):7103-10. PubMed ID: 14645269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini.
    Lee JG; Sagui C; Roland C
    J Am Chem Soc; 2004 Jul; 126(27):8384-5. PubMed ID: 15237988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Increase of non-amidated muropeptides in the cell wall of vancomycin-resistant Staphylococcus aureus (VRSA) strain Mu50].
    Hanaki H; Labischinski H; Inaba Y; Hiramatsu K
    Jpn J Antibiot; 1998 Apr; 51(4):272-80. PubMed ID: 9644600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S. aureus.
    Sieradzki K; Tomasz A
    Antimicrob Agents Chemother; 2006 Feb; 50(2):527-33. PubMed ID: 16436706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms.
    Jefferson KK; Goldmann DA; Pier GB
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2467-73. PubMed ID: 15917548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.
    Ishii K; Tabuchi F; Matsuo M; Tatsuno K; Sato T; Okazaki M; Hamamoto H; Matsumoto Y; Kaito C; Aoyagi T; Hiramatsu K; Kaku M; Moriya K; Sekimizu K
    Sci Rep; 2015 Nov; 5():17092. PubMed ID: 26603341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The escalating challenge of vancomycin resistance in Staphylococcus aureus.
    Pfeltz RF; Wilkinson BJ
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):273-94. PubMed ID: 15578969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
    Hiramatsu K
    Lancet Infect Dis; 2001 Oct; 1(3):147-55. PubMed ID: 11871491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure.
    Filice G; Lanzarini P; Orsolini P; Soldini L; Perversi L; Carnevale G; Comolli G; Castelli F
    Microbiologica; 1990 Jul; 13(3):231-7. PubMed ID: 1703262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus.
    Sieradzki K; Tomasz A
    J Bacteriol; 1997 Apr; 179(8):2557-66. PubMed ID: 9098053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rationale for revising the Clinical and Laboratory Standards Institute vancomycin minimal inhibitory concentration interpretive criteria for Staphylococcus aureus.
    Tenover FC; Moellering RC
    Clin Infect Dis; 2007 May; 44(9):1208-15. PubMed ID: 17407040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus.
    Cui L; Lian JQ; Neoh HM; Reyes E; Hiramatsu K
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3404-13. PubMed ID: 16048954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.